QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4) 期刊论文 ANNALS OF ONCOLOGY, 2016, 卷号: 27, 期号: 3 作者:  Motzer, R. J.;  Alyasova, A.;  Ye, D.;  Karpenko, A.;  Li, H. 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 everolimus  metastatic renal cell carcinoma  sequential targeted therapy  second-line  prospective study   Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4) 期刊论文 2016, 卷号: 27, 期号: 3, 页码: 441-448 作者:  Motzer, R. J.;  Alyasova, A.;  Ye, D.;  Karpenko, A.;  Li, H. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 everolimus  metastatic renal cell carcinoma  sequential targeted therapy  second-line  prospective study   RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis 会议论文 作者:  Alekseev, B.;  Yang, L.;  Alyasova, A.;  Ye, D.;  Karpenko, A. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis 会议论文 作者:  Yang, L.;  Alyasova, A.;  Ye, D.;  Karpenko, A.;  Li, H. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis 会议论文 作者:  Yang, L.;  Alyasova, A.;  Ye, D.;  Karpenko, A.;  Li, H. 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis 会议论文 EUROPEAN JOURNAL OF CANCER, 2015-09-01 作者:  Alekseev, B.;  Yang, L.;  Alyasova, A.;  Ye, D.;  Karpenko, A. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis 会议论文 EUROPEAN JOURNAL OF CANCER, 2015-09-01 作者:  Yang, L.;  Alyasova, A.;  Ye, D.;  Karpenko, A.;  Li, H. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis 期刊论文 2015, 卷号: 51, 页码: S518-S519 作者:  Alekseev, B.;  Yang, L.;  Alyasova, A.;  Ye, D.;  Karpenko, A. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis 期刊论文 2015, 卷号: 26, 页码: 72-72 作者:  Yang, L.;  Alyasova, A.;  Ye, D.;  Karpenko, A.;  Li, H. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma 期刊论文 2013, 卷号: 369, 期号: 8, 页码: 722-731 作者:  Motzer, Robert J.;  Hutson, Thomas E.;  Cella, David;  Reeves, James;  Hawkins, Robert 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13